Heartflow Sues Cardiac AI Rival Cleerly Over Alleged IP Theft
HeartFlow, which makes AI tools to analyze cardiac images, sued its rival Cleerly, alleging infringement on six patents. Cleerly is pushing back.
Moderna to Pay Up to $2.25B to Settle Patent Suit Over Covid-19 Vaccine Technology
Under the settlement, Genevant Sciences and Arbutus Biopharma will grant Moderna a non-exclusive license to their lipid nanoparticle technology for mRNA delivery in infectious disease vaccines. If Moderna's full financial payout to the companies is reached, it would rank among the largest disclosed patent settlements in biopharmaceutical industry history.
presented by
Inside an Automated Healthcare Practice: Redesigning Care Around People, Not Paperwork
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.
BioNTech to Pay CureVac, GSK $740M Plus Royalties to Settle mRNA Patent Disputes
The deal helps move BioNTech’s proposed acquisition of CureVac closer to completion. With the settlement, GSK said it will tender the CureVac shares it owns in support of the $1.25 billion acquisition.
Medtronic-Hexagon Health Lawsuit Highlights the Struggle Between Doctors & Industry
A Beverly Hills surgeon has sued Medtronic, alleging that the medical device giant stole her design for a hernia mesh device. One lawyer pointed out that this is not a typical patent infringement case.
AliveCor Isn’t Backing Down from Apple, Its ‘Bully’
AliveCor CEO Priya Abani argues that Apple has made a habit of taking intellectual property from smaller medical device firms in order to improve the functionalities its Apple Watch. She also believes that Apple has been able to avoid taking accountability for this by “bombarding” smaller companies with litigation it knows they won’t be able to afford — a claim that medical IP lawyers have backed up.
Gilead to pay Merck $2.54B in largest-ever patent infringement case
A federal jury has awarded $2.54 billion in royalties to Merck, ruling against Gilead in a monumental patent infringement case involving two blockbuster hepatitis C drugs. The kicker? The judge has the power to triple that figure.
The Hidden Administrative Tasks Draining Small Practices
Small practices play a critical role in healthcare delivery, but they cannot continue to absorb ever-increasing administrative demands without consequences.
Bet on Medtronic winning the MDT vs. BSX Supreme Court case. Here’s why
The Supreme Court heard oral arguments in Medtronic (MDT) vs. Boston Scientific (BSX) in a patent litigation lawsuit Tuesday. Chances are the Minnesota-based medical device company will win this one. Luckily for Boston Scientific, logic doesn’t always play into legal interpretation. In 1991, Boston Scientific made a licensing agreement with Medtronic for its CRT medical […]
Healthcare startups: Patent trolls got you down? Check out WSJ’s tips
When a startup gets ready for some M&A action (and if they’re in healthcare, getting to this point was probably hard-fought and hard-won), a patent troll could come knocking. While the Federal Trade Commission is finally looking into patent trolls’ effect on innovation, patent trolls still lurk, according to a blog in the Wall Street […]
7 things you should know about protecting IP under the updated patent laws
Passed in September 2011, the final phases of the America Invents Act went into effect in March. Cyrus Morton, a partner at the Minneapolis office of Robins, Kaplan, Miller & Ciresi said this law represents the biggest change since the 1950s. “This bill spent eight years in Congress and finally got passed when this administration […]
How to choose a patent attorney to defend your medical device invention
When selecting a lawyer to defend your patent application, consider experience drafting and a prosecuting application, defending patents after they are issued as well as general business experience.
Beyond Analytics: How Sellers Dorsey is Hard-Coding Value into Medicaid Policy [Video]
How to turn analytics into actual policy outcomes.
Two views: Diagnostics firms may be worried but there are Prometheus write arounds
The biotech industry has moved swiftly to decry the Supreme Court’s Prometheus decision where the nine justices ruled unanimously in favor of Mayo Clinic that natural bodily responses to medical treatment are not patent eligible. In an interview with MedCity News, Kevin Noonan, a partner with intellectual property law firm McDonnell Boehnen Hulbert & Berghoff, said that the […]
Patent decision favors BDSI; USPTO rejects 222 MonoSol Rx claims
Specialty pharmaceutical company BioDelivery Sciences International (NASDAQ:BDSI) can now claim patent victories against all three patent challenges levied by a rival in a long-running patent dispute. The U.S. Patent and Trademark Office has rejected all claims made by MonoSol Rx in the third MonoSol patent that the New Jersey company alleged BDSI had infringed. In […]
Patent ruling favors BDSI; MonoSol still claims infringement on other patents
BioDelivery Sciences International (NASDAQ:BDSI) has a patent victory against a competitor who claims the North Carolina pharmaceutical company’s drug delivery platform infringes on its technology. The United States Patent and Trademark Office rejected all 191 claims made by New Jersey-based MonoSol Rx as unpatentable. The dispute centers on the technology that forms BDSI’s drug-delivery platform. […]
Migraine drug patents for Pozen’s Treximet upheld by judge
Migraine headache treatment Treximet, developed by pharmaceutical company Pozen (NASDAQ:POZN), has won a patent victory against generics companies looking to introduce their versions of the drug. A federal judge in Texas has ruled that two Treximet patents are valid and enforceable, and were infringed by Par Pharmaceutical (NYSE:PRX), Alphapharm and Dr. Reddy’s Laboratories (NYSE:RDY). A […]